Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sobel

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|April 2, 2010
An agitated young manFarhana Mann, Anna Sobel
Endokrynologia Polska|June 15, 2006
The rising incidence of type 1 diabetes in south-eastern Poland. A study of the 0-29 year-old age group, 1980-1999Anna Sobel-Maruniak, Marek Grzywa, Renata Orłowska-Florek, et al.
Anticancer Research|September 27, 2015
The New Semisynthetic Cardenolide Analog 3β-[2-(1-Amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) Efficiently Suppresses Cell Growth in Human Leukemia and Urological Tumor Cell LinesElke Nolte, Anna Sobel, Sven Wach, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|April 2, 2010
An agitated young manFarhana Mann, Anna Sobel
Endokrynologia Polska|June 15, 2006
The rising incidence of type 1 diabetes in south-eastern Poland. A study of the 0-29 year-old age group, 1980-1999Anna Sobel-Maruniak, Marek Grzywa, Renata Orłowska-Florek, et al.
Anticancer Research|September 27, 2015
The New Semisynthetic Cardenolide Analog 3β-[2-(1-Amantadine)-1-on-ethylamine]-digitoxigenin (AMANTADIG) Efficiently Suppresses Cell Growth in Human Leukemia and Urological Tumor Cell LinesElke Nolte, Anna Sobel, Sven Wach, et al.
Pageof 1